We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
-1.75%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$198B
AUM Growth
-$4.65B
Cap. Flow
+$2.83B
Cap. Flow %
1.43%
Top 10 Hldgs %
21.4%
Holding
6,895
New
836
Increased
2,327
Reduced
2,312
Closed
834

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$689M
2
HD icon
Home Depot
HD
+$377M
3
CI icon
Cigna
CI
+$322M
4
VLO icon
Valero Energy
VLO
+$250M
5
APH icon
Amphenol
APH
+$242M

Sector Composition

Rank Sector Weight
1 Technology 9.2%
2 Healthcare 7.6%
3 Financials 5.15%
4 Consumer Discretionary 5.03%
5 Industrials 4.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RETA
6676
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-556,264
Closed -$56.7M
RETA
6677
PUT
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-35,400
Closed -$3.61M
RBT
6678
DELISTED
Rubicon Technologies, Inc.
RBT
-4,925
Closed -$14.6K
GFGDR
6679
DELISTED
The Growth for Good Acquisition Corporation Right
GFGDR
-564,000
Closed -$79K
GFGDW
6680
CALL
DELISTED
The Growth for Good Acquisition Corporation Warrant
GFGDW
-282,000
Closed -$22.6K
GFGD
6681
DELISTED
The Growth for Good Acquisition Corporation Class A Ordinary Shares
GFGD
-564,000
Closed -$5.89M
ADERW
6682
CALL
DELISTED
26 Capital Acquisition Corp Warrant
ADERW
-67,500
Closed -$4.46K
SUNL.WS
6683
CALL
DELISTED
Sunlight Financial Holdings, Inc. Warrants, exercisable for 1/20th of a share of Class A Common Stock at an exercise price of $230.00
SUNL.WS
-376,613
Closed -$6.37K
DBTX
6684
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
-159,224
Closed -$613K
FATH.WS
6685
CALL
DELISTED
Fathom Digital Manufacturing Corporation Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50 per share
FATH.WS
-134,912
Closed -$1.75K
BRDS.WS
6686
CALL
DELISTED
Bird Global, Inc. Warrants each whole warrant exercisable to purchase 1/25th of a share of Class A Common Stock at an exercise price of $287.50 per share
BRDS.WS
-65,800
Closed -$1.7K
BRDS
6687
DELISTED
Bird Global, Inc.
BRDS
-96,941
Closed -$196K
RADI
6688
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
-725,694
Closed -$10.8M
MBSC
6689
DELISTED
M3-Brigade Acquisition III Corp.
MBSC
-453,300
Closed -$4.74M
MBSC.WS
6690
CALL
DELISTED
M3-Brigade Acquisition III Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
MBSC.WS
-151,100
Closed -$66.5K
AXLA
6691
DELISTED
Axcella Health Inc. Common Stock
AXLA
-2,891
Closed -$15.8K
HHRSW
6692
CALL
DELISTED
Hammerhead Energy Inc. Warrant
HHRSW
-205,621
Closed -$290K
UTAA
6693
DELISTED
UTA Acquisition Corporation Class A Ordinary Shares
UTAA
-340,000
Closed -$3.59M
TKAT
6694
DELISTED
Takung Art Co., Ltd.
TKAT
-10,605
Closed -$3.71K
PIAI.WS
6695
CALL
DELISTED
Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PIAI.WS
-449,733
Closed -$18.4K
INFI
6696
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
-250,560
Closed -$52.7K
NSTD.WS
6697
CALL
DELISTED
Northern Star Investment Corp. IV Redeemable Warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTD.WS
-168,331
Closed -$9.64K
WWE
6698
DELISTED
World Wrestling Entertainment
WWE
-1,043,655
Closed -$113M
RTL
6699
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
-437,090
Closed -$2.95M
LFLY
6700
DELISTED
Leafly Holdings, Inc. Common Stock
LFLY
-2,919
Closed -$16.9K

Similar funds

Millennium Management's Q3 2023 Portfolio in Review

As of Q3 2023, Millennium Management held 6,895 positions worth $198B, down 2.3% from $203B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Millennium Management's Q3 2023 filing shows 836 new, 2,327 increased, 2,312 reduced and 834 closed positions. Its largest new stake was Mobileye: 2,953,164 shares worth $123M. The largest sale was iShares Core S&P 500 ETF, an estimated $689M.

By sector, the portfolio is most concentrated in Technology at 9.2% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Financials.

  • Millennium Management's largest Q3 2023 buy was Mobileye: 2,953,164 shares worth $123M.
  • Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $3.7B increase.
  • Millennium Management's biggest Q3 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $689M.
  • Millennium Management fully exited Blackstone in Q3 2023, selling an estimated $178M.
  • Millennium Management's ten largest holdings make up 21% of its $198B portfolio in Q3 2023.
  • Millennium Management opened 836 new positions and closed 834 in Q3 2023.
  • Millennium Management's portfolio value fell 2.3% quarter-over-quarter to $198B.

Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.